Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcelo Facciuto

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Langenbeck'S Archives of Surgery|January 28, 2012
Can we direct organ allocation based on predicted outcome? Hepatocellular carcinoma outside of UCSF criteria or retransplant?Caroline Rochon, Patricia Sheiner, Basant Mahadevappa, et al.
Turkish Journal of Surgery|June 9, 2022
Limited upper midline incision for major hepatectomy in adults: safety and feasibilityAhmad Mahamid, Yaniv Fenig, Salvatore Amodeo, et al.
Hepatology (Baltimore, Md.)|August 8, 2014
Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantationShunji Nagai, Atsushi Yoshida, Marcelo Facciuto, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|June 23, 2010
Massive pulmonary and intracardiac embolism during liver transplantationPaulo N Martins, Leona Kim-Schluger, Manuel Rodriguez-Davalos, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large Hepatocellular Carcinoma: Results From a Prospective Phase 2 TrialMichael Buckstein, Edward Kim, Umut Özbek, et al.
Journal of Hepatology|February 21, 2013
WITHDRAWN: Recurrence prediction of hepatocellular carcinoma after liver transplantation by ischemia time and tumor characteristicsShunji Nagai, Marcelo Facciuto, Shozo Mori, et al.
Pediatric Transplantation|May 28, 2011
Recurrent intrahepatic pigmented stones after liver transplantation in a patient with hemoglobin SC disease: case report and review of the literatureJuli Tomaino, Tara Keegan, Nanda Kerkar, et al.
The American Journal of Surgical Pathology|May 17, 2011
Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literatureJaclyn F Hechtman, Mohammad Raoufi, M Isabel Fiel, et al.
Surgery|April 18, 2022
Two hundred and fifty-one right hepatectomies for living donation: Association between preoperative risk factors, hepatic dysfunction, and complicationsAhmad Mahamid, Yaniv Fenig, Salvatore Amodeo, et al.
Digestive Diseases and Sciences|September 28, 2005
Potentiation of acetaminophen hepatotoxicity by phenytoin, leading to liver transplantationScott M Suchin, David C Wolf, Young Lee, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Langenbeck'S Archives of Surgery|January 28, 2012
Can we direct organ allocation based on predicted outcome? Hepatocellular carcinoma outside of UCSF criteria or retransplant?Caroline Rochon, Patricia Sheiner, Basant Mahadevappa, et al.
Turkish Journal of Surgery|June 9, 2022
Limited upper midline incision for major hepatectomy in adults: safety and feasibilityAhmad Mahamid, Yaniv Fenig, Salvatore Amodeo, et al.
Hepatology (Baltimore, Md.)|August 8, 2014
Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantationShunji Nagai, Atsushi Yoshida, Marcelo Facciuto, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|June 23, 2010
Massive pulmonary and intracardiac embolism during liver transplantationPaulo N Martins, Leona Kim-Schluger, Manuel Rodriguez-Davalos, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Combination Transarterial Chemoembolization and Stereotactic Body Radiation Therapy for Unresectable Single Large Hepatocellular Carcinoma: Results From a Prospective Phase 2 TrialMichael Buckstein, Edward Kim, Umut Özbek, et al.
Journal of Hepatology|February 21, 2013
WITHDRAWN: Recurrence prediction of hepatocellular carcinoma after liver transplantation by ischemia time and tumor characteristicsShunji Nagai, Marcelo Facciuto, Shozo Mori, et al.
Pediatric Transplantation|May 28, 2011
Recurrent intrahepatic pigmented stones after liver transplantation in a patient with hemoglobin SC disease: case report and review of the literatureJuli Tomaino, Tara Keegan, Nanda Kerkar, et al.
The American Journal of Surgical Pathology|May 17, 2011
Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literatureJaclyn F Hechtman, Mohammad Raoufi, M Isabel Fiel, et al.
Surgery|April 18, 2022
Two hundred and fifty-one right hepatectomies for living donation: Association between preoperative risk factors, hepatic dysfunction, and complicationsAhmad Mahamid, Yaniv Fenig, Salvatore Amodeo, et al.
Digestive Diseases and Sciences|September 28, 2005
Potentiation of acetaminophen hepatotoxicity by phenytoin, leading to liver transplantationScott M Suchin, David C Wolf, Young Lee, et al.
Pageof 3